{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:36:55Z","timestamp":1778701015419,"version":"3.51.4"},"reference-count":34,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Human epidermal growth factor receptor 2 (HER2) gene status and overexpression, occurring in ~\u00a013.6% of primary breast cancers, is essential for identifying patients likely to benefit from biological treatment. In this method of evaluation study, we tested and compared the HER2 gene\u2013protein assay (GPA) with routine HER2 immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). The GPA was evaluated using 67 formalin\u2010fixed paraffin\u2010embedded (FFPE) HER2 equivoval IHC (2+) breast cancer tissue samples. Overall, agreement between GPA silver in situ hybridization (SISH) and FISH was 91.9% (57\/62). Regression analysis revealed slightly higher, but non\u2010significant difference in <jats:italic>HER2\/chromosome enumeration probe 17<\/jats:italic> (<jats:italic>CEP17<\/jats:italic>) ratio for GPA as compared to FISH (p\u00a0=\u00a00.074). Intraclass correlation coefficients (ICCs) of 0.94 and Spearman\u00b4s rank correlation coefficients of 0.93 (p\u00a0&lt;\u00a00.0001) for FISH and GPA SISH suggested strong inter\u2010observer association for methods with one observer counting on average 0.23 significant higher for GPA SISH (p\u00a0=\u00a00.014). Intra\u2010observer IHC method reproducibility was 52.6% (\u03ba\u00a0=\u00a00.3122, p\u00a0=\u00a00.004) and 79.7% (\u03ba\u00a0=\u00a00.6428, p\u00a0=\u00a00.9197), suggesting fair significant and substantial non\u2010significant difference between tests for reviewers. Inter\u2010observer reproducibility for IHC methods was 53%. While inter\u2010observer reproducibility for experienced IHC interpretation suggested significant differences (\u03ba\u00a0=\u00a00.3636, p\u00a0=\u00a00.0332), unexperienced interpretation of IHC GPA suggested fair non\u2010significant difference between reviewers (\u03ba\u00a0=\u00a00.3101, p\u00a0=\u00a00.0747). Using FISH as reference, the diagnostic indices for GPA SISH were as follows: sensitivity 100%, specificity 95% and accuracy 92%. Inaccuracy between tests was in 80% of cases due to ISH categorization as equivocal by one of the methods. IHC results highlight that it may be beneficial with a method for simultaneously visualization of HER2 gene and protein status.<\/jats:p>","DOI":"10.1111\/apm.13076","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T04:54:21Z","timestamp":1598676861000},"page":"573-582","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of analytical accuracy of HER2 status in patients with breast cancer"],"prefix":"10.1111","volume":"128","author":[{"given":"Steffen Grann","family":"Jensen","sequence":"first","affiliation":[{"name":"Department of Pathology Herlev\u2010Gentofte Hospital Herlev Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Engel","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Pathology Herlev\u2010Gentofte Hospital Herlev Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ib Jarle","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Pathology Herlev\u2010Gentofte Hospital Herlev Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Balslev","sequence":"additional","affiliation":[{"name":"Department of Pathology Herlev\u2010Gentofte Hospital Herlev Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Pathology Herlev\u2010Gentofte Hospital Herlev Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estrid","family":"H\u00f8gdall","sequence":"additional","affiliation":[{"name":"Department of Pathology Herlev\u2010Gentofte Hospital Herlev Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5041\/RMMJ.10321","article-title":"The risk of cancer might be lower than we think. alternatives to lifetime risk estimates","volume":"9","author":"Grunau GL","year":"2018","journal-title":"Rambam Maimonides Med J"},{"key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr2322","article-title":"HER\u20102 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005","volume":"11","author":"K\u00f6ninki K","year":"2009","journal-title":"Breast Cancer Res"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008-0230"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPV2I0HGPMGBSQ"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPT41TCBUEVDQC"},{"key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758835919833519","article-title":"HER2\u2010positive breast cancer: new therapeutic frontiers and overcoming resistance","volume":"11","author":"Pernas S","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2008.03.013"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.177"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2656"},{"key":"e_1_2_10_12_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications","volume":"14","author":"Iqbal N","year":"2014","journal-title":"Mol Biol Int"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-015-1781-0"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.9984"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1033"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.08.005"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.556"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2014.11.009"},{"key":"e_1_2_10_19_1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.rpor.2011.10.005","article-title":"Comparison of in situ hybridization methods for the assessment of HER\u20102\/neu gene amplification status in breast cancer using a tissue microarray","volume":"17","author":"Malicka\u2010Durczak A","year":"2012","journal-title":"Rep Pract Oncol Radiother"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2012.15.4.381"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2012.02862.x"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20132483"},{"key":"e_1_2_10_23_1","first-page":"2771","article-title":"Sensitivity of HER\u20102\/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression","volume":"54","author":"Press MF","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880007"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12407"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1309\/VACP-VLQA-G9DX-VUDF"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.9"},{"key":"e_1_2_10_28_1","first-page":"1","article-title":"A gene\u2010protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin\u2010fixed, paraffin\u2010embedded breast cancer tissue sections","volume":"60","author":"Nitta H","year":"2012","journal-title":"Diagn Pathol"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-3856-2"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.07.005"},{"key":"e_1_2_10_31_1","first-page":"1","article-title":"The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual\u2010colour silver in situ hybridization on one slide for gastric carcinoma testing","volume":"160","author":"Werner D","year":"2014","journal-title":"J Transl Med"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2012.031"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPL5IV0LAWSERG"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPKIVVW4OBPX6I"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2015.04.002"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apm.13076","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/apm.13076","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apm.13076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:18:55Z","timestamp":1693873135000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apm.13076"}},"subtitle":["Comparison of HER2 GPA with HER2 IHC and <i>HER2<\/i> FISH"],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1111\/apm.13076"],"URL":"https:\/\/doi.org\/10.1111\/apm.13076","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"2020-02-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}